Uditha Dealwis

Vice President, Analytical Development and Quality Control @Sarepta Therapeutics

Andover, MA, US

Lead the Sarepta Analytical Development and Quality Control functions for AAV Gene Therapy and RNA Therapies. Develop and validate novel AAV analytical methods including in-vivo and in-vitro potency, Mass spectrophotometric methods, PCR, HPLC, Electrophoresis based methods for QC use. Manage the in-house team of subject matter experts engaged in developing novel methods and validating test methods for QC use. Manage the quality control activities required by late phase programs in RNA and GT areas. Develop AAV gene therapy release capacity for clinical and commercial materials in the US and ROW.

University of Arizona

Ph.D., Bioanalytical Chemistry with Biochemistry minor

University of Peradeniya

BSc (Hons), Chemistry with Botany minor